Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report

BACKGROUND Dedifferentiated chondrosarcoma (DDCS) accounts for 10% of all chondrosarcomas and has the poorest outcome, with a 5-year survival rate of 7%-25%. DDCS commonly occurs in the femur and pelvis, whereas DDCS of the finger is extremely rare. Furthermore, the histological findings of preexisting solitary enchondroma samples are important and valuable for diagnosing malignant transformations. CASE SUMMARY We report our experience with DDCS in the proximal phalanx of the left middle finger of an 87-year-old woman. She had undergone surgery for enchondroma, with curettage and artificial bone grafting, 11 years ago, in the same location. Several years after the primary surgery, the left middle finger gradually started to enlarge, and the growth speed increased in the past year. Plain radiographs showed an expansive osteolytic lesion with calcifications and residual grafting material. Owing to the suspicion of malignancy, we performed ray amputation. Histological findings revealed an abrupt transition between the low-grade chondrosarcoma and dedifferentiated sarcoma components. The dedifferentiated components showed the features of a high-grade undifferentiated pleomorphic sarcoma. The patient was diagnosed with DDCS arising from a preexisting enchondroma. She had no local recurrence or distant metastasis and died of pneumonia 6 years and 10 months after the second surgery. CONCLUSION The histological findings of a precursor lesion showed a typical enchondroma, suggesting that DDCS can arise from enchondroma.

[1]  Tingting Yang,et al.  Clonality analysis and IDH1 and IDH2 mutation detection in both components of dedifferentiated chondrosarcoma, implicated its monoclonal origin , 2020, Journal of bone oncology.

[2]  A. B. Mallick,et al.  Survival and Prognosis of Chondrosarcoma Subtypes: SEER Database Analysis , 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[3]  R. Grimer,et al.  Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment , 2018, Clinical Sarcoma Research.

[4]  S. Kliethermes,et al.  Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001‐2011) , 2017, Journal of surgical oncology.

[5]  W. Yao,et al.  Dedifferentiated chondrosarcoma: Radiological features, prognostic factors and survival statistics in 23 patients , 2017, PloS one.

[6]  C. Morris,et al.  Acral Dedifferentiated Chondrosarcoma of a Toe Phalanx: A Case Report. , 2014, JBJS case connector.

[7]  D. Campanacci,et al.  Dedifferentiated peripheral chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of four cases , 2012, Virchows Archiv.

[8]  F. Oztop,et al.  Dedifferentiated chondrosarcoma of the thumb: a case report , 2009, Archives of Orthopaedic and Trauma Surgery.

[9]  D. Biau,et al.  Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. , 2007, European journal of cancer.

[10]  A. Nerlich,et al.  Malignant Transformation of a Benign Enchondroma of the Hand to Secondary Chondrosarcoma with Isolated Pulmonary Metastasis , 2004, Acta chirurgica Belgica.

[11]  A. Wilson,et al.  From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  R. Schneider-Stock,et al.  Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma , 2000, Virchows Archiv.

[13]  A. Cleton-Jansen,et al.  Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis , 1999, The Journal of pathology.

[14]  Y. Iwamoto,et al.  Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma , 1999, Journal of Cancer Research and Clinical Oncology.

[15]  H. Sissons,et al.  Dedifferentiated chondrosarcoma. Report of an unusual case. , 1991, Journal of Bone and Joint Surgery. American volume.

[16]  F. Sim,et al.  Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases. , 1986, The Journal of bone and joint surgery. American volume.

[17]  S. Chawla,et al.  Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma): I. A clinicopathologic study of 26 cases , 1986, Cancer.

[18]  F. McCue,et al.  Chondrosarcoma of the hand arising from a pre-existent benign solitary enchondroma. , 1975, Clinical orthopaedics and related research.

[19]  D. Dahlin,et al.  Dedifferentiation of low‐grade chondrosarcomas , 1971, Cancer.

[20]  T. Ishida,et al.  Dedifferentiated chondrosarcoma of humerus with giant cell tumor-like features , 2006, Skeletal Radiology.

[21]  M. Mercuri,et al.  Dedifferentiated chondrosarcoma , 1988, The Journal of bone and joint surgery. American volume.